4.4 Letter

Basophil count is a sensitive marker for clinical progression in a chronic spontaneous urticaria patient treated with omalizumab

Journal

ALLERGOLOGY INTERNATIONAL
Volume 68, Issue 3, Pages 388-390

Publisher

JAPANESE SOCIETY ALLERGOLOGY
DOI: 10.1016/j.alit.2019.02.002

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available